UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Davis Capital Management

Davis Capital Management reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 1,035 shares of the healthcare conglomerate’s stock after selling 59 shares during the period. Davis Capital Management’s holdings in UnitedHealth Group were worth $542,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.6%

Shares of NYSE:UNH opened at $295.61 on Friday. The firm’s 50-day moving average is $413.43 and its two-hundred day moving average is $486.09. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The firm has a market capitalization of $268.16 billion, a PE ratio of 19.07, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the business earned $6.91 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.99%. The ex-dividend date is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is 35.18%.

Analyst Ratings Changes

A number of equities analysts have weighed in on UNH shares. TD Securities reissued a “hold” rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Oppenheimer dropped their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Truist Financial reaffirmed a “buy” rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a research report on Monday, May 19th. Finally, Piper Sandler lowered their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $428.43.

Insider Activity

In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of the business’s stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.